Clinical trial NCT04339582: GENETIC BASIS of LEFT VENTRICULAR APICAL HYPOPLASIA
Official title: GENETIC BASIS of LEFT VENTRICULAR APICAL HYPOPLASIA
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Left Ventricular Apical Hypoplasia (LVAH), New Rare Condition
Keywords: Left ventricular apical hypoplasia (LVAH)
Genetic testing
Congenital or genetical condition
Lead sponsor: Monaldi Hospital
Sponsor class: OTHER
Collaborators: name: Bambino Gesù Hospital and Research Institute
First posted: 2020-04-09
Enrollment: 7
Sex: ALL
Maximum age (years): 90
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: The study population is composed by consecutive patients with diagnosis of LVAH. Diagnosis of LVAH is based on echocardiographic or cardiac magnetic resonance (CMR) evidence of all the following diagnostic criteria:

* a spherical, truncated LV with some degree of systolic dysfunction;
* an elongated, normally functioning right ventricle that wraps around the distal left ventricle;
* deficiency of the myocardium within the LV apex with adipose tissue infiltrating the apex;
* origin of the papillary muscle in the flattened anterior apex. Patients enrolled followed a common protocol designed by GL (Monaldi Hospital, AORN Colli, University of Campania "Luigi Vanvitelli"). The study protocol was approved, and written informed consent was obtained from each subject, according to the procedure established by the Ethic Committee of our institution.

Brief summary: Brief summary Left ventricular apical hypoplasia (LVAH) is a rare cardiomyopathy characterized by a spherical, truncated LV with some degree of systolic dysfunction, an elongated, normally functioning right ventricle that wraps around the distal left ventricle, deficiency of the myocardium within the LV apex with adipose tissue infiltrating the apex and origin of the papillary muscle in the flattened anterior apex. This condition presents with different clinical presentation, ranging from no symptoms to congestive heart failure or malignant tachycardia. The etiology of this condition is currently unknown. The aim of this study is to evaluate the clinical and genetic characteristics of patients with LVAH.

Background Left ventricular apical hypoplasia (LVAH) is described as congenital heart disease with an unusual type of cardiomyopathy that was first described in 2004 by Fernandez-Valls et al. It is an extremely rare disease; to date, only more than twenty cases were described.

The typical imaging features of this cardiomyopathy include: a spherical, truncated LV with some degree of systolic dysfunction; an elongated, normally functioning right ventricle that wraps around the distal left ventricle; deficiency of the myocardium within the LV apex with adipose tissue infiltrating the apex; origin of the papillary muscle in the flattened anterior apex. A 2D echocardiogram and cardiac MRI can successfully indicate different morphological features This rare phenomenon frequently presents with different clinical manifestations according to the age of the disease, from no symptoms in children to congestive heart failure, pulmonary edema, or even malignant tachycardia in adults. Congenital or genetical etiology was proposed to explain the development of this rare cardiomyopathy.

The aim of this study is to evaluate the clinical and genetic characteristics of patients with LVAH.

Methods Study population

The study population is composed by consecutive patients with diagnosis of LVAH. Diagnosis of LVAH is based on echocardiographic or cardiac magnetic resonance (CMR) evidence of all the following diagnostic criteria:

* a spherical, truncated LV with some degree of systolic dysfunction;
* an elongated, normally functioning right ventricle that wraps around the distal left ventricle;
* deficiency of the myocardium within the LV apex with adipose tissue infiltrating the apex;
* origin of the papillary muscle in the flattened anterior apex. Patients enrolled followed a common protocol designed by GL (Monaldi Hospital, AORN Colli, University of Campania "Luigi Vanvitelli"). The study protocol was approved, and written informed consent was obtained from each subject, according to the procedure established by the Ethic Committee of our institution.

Study protocol Patients enrolled underwent a comprehensive clinical-genetic evaluation commonly practiced in our cardiology division. In particular, the basal evaluation, consisted family and personal history, physical examination, blood tests, 12-lead electrocardiogram (ECG) at rest, conventional M-mode, two-dimensional and Doppler echocardiography, 24-hour Holter ECG, and cardiac magnetic resonance (CMR), and genetic testing with whole exome sequencing (WES). Moreover, all patients are clinically revaluated every 6-12 months.


Eligibility criteria: Inclusion Criteria:

* Male and female patients, 0-90 years old, in any distribution.
* Patients who have the diagnostic criteria for LVAH. Diagnosis of LVAH is based on echocardiographic or cardiac magnetic resonance (CMR) evidence of all the following diagnostic criteria:

  * a spherical, truncated LV with some degree of systolic dysfunction;
  * an elongated, normally functioning right ventricle that wraps around the distal left ventricle;
  * deficiency of the myocardium within the LV apex with adipose tissue infiltrating the apex;
  * origin of the papillary muscle in the flattened anterior apex.

Exclusion Criteria:

* Involvement with any other ongoing studies.
* Patients who have diagnosis of other Cardiomyopathies

Primary outcomes:
measure: new gene of LVAH
timeFrame: one year later the completation study
Secondary outcomes:
Other outcomes:
Locations:
city: Naples
country: Italy
facility: Ospedale V. Monaldi, Università degli studi della Campania, Luigi Vanvitelli
Study officials:
References: